Rivastigmine tartrate
HealthData.Gov
Updated Mar 25, 2026
About this dataset
Rivastigmine Tartrate is a generic prescription medication, available as oral capsules in strengths of 1.5 mg, 3 mg, 4.5 mg, and 6 mg. Manufactured by Sun Pharmaceutical Industries, Inc., it acts as a cholinesterase inhibitor to help manage symptoms of mild to moderate Alzheimer's disease dementia. This product has been discontinued. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Rivastigmine tartrate
Access the FDA dataset for Rivastigmine tartrate โ ANDA 203308 submitted by Mylan Institutional LLC
Modified Dec 27, 2025